Prior to joining Duoning, he worked at Biological E in Hyderabad, India. In his role as Assistant General Manager, he led the commercial manufacturing of polysaccharide conjugate and protein-based Vaccines. Before that, he worked for Panacea Biotech, Sartorius, Sanofi and Krebs Biochemical Industries.
Dr Ramesh Mundlamuri is well-versed in cGMP, GLP, GDP and various regulatory bodies (WHO, EU, ROW, FDA, NRA). He also possesses extensive experience in the management of several vaccines, including polysaccharide vaccines, recombinant viral proteins, conventional vaccines and carrier protein.
Attributed to the BioE3 (Biotechnology for Economy, Employment and Environment) Policy, India's bioeconomy has seen exponential growth, ballooning from $10 billion in 2014 to a staggering $130 billion in 2024, with expectations to reach $300 billion by 2030. This policy also emphasizes the strategic objective of transitioning from chemical-based industries to sustainable bio-based models, promoting a circular bioeconomy. In this context, India has attracted numerous international biopharmaceutical companies to engage in business, which have absorbed a large number of local talents to better meet the demands of the domestic market. Dr Ramesh Mundlamuri joined Duoning Biotech (a comprehensive bioprocessing solutions provider) as the Head of Technology in 2023. In a discussion, he talked about the opportunities available in the Indian market and shared his insights and experiences in conducting bioprocessing business within the country.
We notice that most of Duoning's product offerings are centered around biomanufacturing, which may require customization or extensive testing. How do you provide support to local customers quickly and efficiently?
Bu hikaye Bio Spectrum dergisinin BioSpectrum India Oct 2024 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Giriş Yap
Bu hikaye Bio Spectrum dergisinin BioSpectrum India Oct 2024 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Giriş Yap
Study reveals role of Ayurvedic Whole System in management of Rheumatoid Arthritis
A new scientific study has revealed the significant effectiveness of the Ayurvedic Whole System (AWS) in the management of Rheumatoid Arthritis (RA), a chronic autoimmune disorder affecting millions worldwide.
Amit Mookim steps in as CEO of Immuneel Therapeutics
Bengaluru-based Immuneel Therapeutics, a pioneering cell and gene therapy platform, has announced the appointment of Amit Mookim as its new Chief Executive Officer (CEO).
Meril expands healthcare education network with opening of Satellite Academy in Kochi
Meril, a global medical technology and education leader, has expanded its healthcare education network by launching the Meril Satellite Academy in Kerala’s port city, Kochi.
Skye Air Mobility partners with CARITAS Hospital for drone-based medical deliveries in Kottayam
New Delhi-based startup Skye Air Mobility, a leading drone technology-based logistics firm, has announced a collaboration with CARiTAS Hospital & Institute of Health Sciences, Kottayam, Kerala, to revolutionise medical deliveries through drone technology.
Pristyn Care partners with CureMyKnee to establish CoE for joint replacement surgeries
Gurugram-based startup Pristyn Care, a leading healthcare provider specialising in advanced secondary care surgeries, is establishing a Centre for Excellence (CoE) in Joint Replacement Surgeries with Cure My Knee.
Vipragen, Zumutor form strategic alliance in biologics CRO sector
Bengaluru-based companies Vipragen Biosciences and Zumutor Biologics have announced a strategic partnership to set up an endto-end Biologics Contract Research Organisation (CRO) platform to support discovery, clone to preclinical development of biologics/biosimilars.
Cambrian Bioworks raises $1.45 M to transform molecular diagnostics in India
Bengaluru-based biotechnology startup Cambrian Bioworks has secured $1.45 million in seed funding.
Health Minister introduces National Medical Register Portal of National Medical Commission
Union Minister for Health & Family Welfare, Jagat Prakash Nadda recently inaugurated the National Medical Register (NMR) Portal of the National Medical Commission (NMC) for registration of all the MBBS doctors who are eligible for registration in India, in presence of Union Minister of State (MoS) for Health & Family Welfare, Anupriya Patel and virtual presence of Union MoS for Health & Family Welfare, Prataprao Jadhav.
Centre launches National Strategy For Prevention of Unintentional Injury
The Ministry of Health and Family Welfare, Government of India and World Health Organization (WHO) released India's National Strategy For Prevention of Unintentional Injury at #Safety2024: 15th World Conference on Injury Prevention and Safety Promotion on September 2 in New Delhi.
"Bridge the gap and accelerate India's advancements in innovative therapies"
Dr Ramesh Mundlamuri has over 19 years of experience in various biopharmaceutical organizations and has ample experience in various divisions and sections of the biopharmaceutical industry, including Research & Development, Technology Transfer, Commercial Manufacturing, Product & Process Development, Operations Management and so on.